Valuation: Abbott Laboratories

Market Cap 188B 163B 152B 139B 262B 17,936B 266B 1,789B 700B 8,972B 706B 690B 29,936B P/E 2026 *
31.2x
P/E 2027 * 24x
Enterprise Value 212B 184B 172B 157B 295B 20,220B 300B 2,017B 789B 10,114B 796B 778B 33,748B EV / Sales 2026 *
4.21x
EV / Sales 2027 * 3.82x
Free-Float
86.16%
Yield 2026 *
2.37%
Yield 2027 * 2.52%
1 day+1.01%
1 week+2.43%
Current month+3.80%
1 month+16.81%
3 months+30.12%
6 months-2.28%
Current year-12.43%
1 week 104.2
Extreme 104.2
110.18
1 month 87.64
Extreme 87.64
110.18
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

416 0.0000%
6/30/26 Free

Director

432 0.0000%
6/30/26 Free

Director

363 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%+2.43%-18.29%+4.75% 188B
+1.42%+4.61%-2.37%+9.10% 114B
+2.73%+8.27%+17.09%+78.51% 62.02B
+2.38%+3.92%+35.52%+60.21% 55.26B
+0.99%+6.58%-6.25%-34.56% 48.93B
+2.14%+2.54%+13.53%-20.96% 33.08B
+3.64%-13.42% - - 29.66B
-0.22%+0.99%+45.81%-12.21% 24.78B
+8.53%+11.42%-5.85%+18.17% 23.91B
-0.28%+2.40%-1.90%+4.84% 23.29B
Average +2.02%+2,960.59%+8.59%+11.98% 60.33B
Weighted average by Cap. +1.37%+2,587.21%+0.71%+13.93%

Financials

2026 *2027 *
Net sales 50.3B 43.58B 40.8B 37.24B 70.02B 4,800B 71.23B 479B 187B 2,401B 189B 185B 8,012B 54.65B 47.35B 44.32B 40.45B 76.07B 5,215B 77.38B 520B 203B 2,609B 205B 201B 8,704B
Net income 6.23B 5.4B 5.05B 4.61B 8.67B 595B 8.82B 59.29B 23.19B 297B 23.39B 22.88B 992B 7.93B 6.87B 6.43B 5.87B 11.04B 757B 11.23B 75.51B 29.53B 379B 29.79B 29.14B 1,264B
Net Debt 23.94B 20.74B 19.41B 17.72B 33.32B 2,284B 33.9B 228B 89.11B 1,143B 89.88B 87.92B 3,813B 20.96B 18.16B 17B 15.51B 29.17B 2,000B 29.67B 199B 78.01B 1,000B 78.69B 76.97B 3,338B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-08-11 US$109.72 +1.01% 6,486,493
26-08-10 US$108.62 +0.75% 5,603,218
26-08-07 US$107.81 -0.14% 6,606,637
26-08-06 US$107.96 +2.13% 9,801,625
26-08-05 US$105.71 +0.24% 9,313,212
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
108.62USD
Average target price
118.42USD
Spread / Average Target
+9.02%

Quarterly revenue - Rate of surprise